# Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents

> **NCT00516386** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 16 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** RhIGF-1

## Key facts

- **NCT ID:** NCT00516386
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516386, "Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00516386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*